AGBL2 and rheumatoid arthritis: However, when seropositivity was defined using a lower cut-off, >2SD above the mean of HCs, 29 UC patients (13%) and 28 CD patients (17%) were seropositive for IgG anti-CCP2, while 2 (5.6%) HCs and 74 (86%) RA patients were seropositive.